Life Biosciences
Jan 17, 2019
Juvenescence raises $46M; Brainsway files for IPO; Life Biosciences raises
Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bai...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
